 Andrew Bradford
Concepts (377)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Endometrial Neoplasms | 7 | 2021 | 163 | 1.820 |
Why?
| | Follicle Stimulating Hormone | 13 | 2023 | 239 | 1.690 |
Why?
| | Luteinizing Hormone | 13 | 2022 | 178 | 1.520 |
Why?
| | E2F1 Transcription Factor | 9 | 2024 | 61 | 1.430 |
Why?
| | Prolactin | 10 | 2022 | 99 | 1.090 |
Why?
| | Hyperlipidemias | 3 | 2022 | 126 | 1.040 |
Why?
| | Obesity | 16 | 2024 | 2869 | 1.030 |
Why?
| | Hyperinsulinism | 3 | 2022 | 119 | 1.020 |
Why?
| | Leiomyoma | 3 | 2019 | 73 | 0.990 |
Why?
| | Uterine Neoplasms | 3 | 2019 | 101 | 0.970 |
Why?
| | Protein Kinase C-alpha | 3 | 2009 | 37 | 0.920 |
Why?
| | Metabolic Syndrome | 4 | 2024 | 341 | 0.860 |
Why?
| | Pituitary Gland | 7 | 2021 | 148 | 0.840 |
Why?
| | Promoter Regions, Genetic | 16 | 2024 | 1207 | 0.780 |
Why?
| | Human Growth Hormone | 1 | 2022 | 45 | 0.770 |
Why?
| | Gene Expression Profiling | 6 | 2019 | 1714 | 0.750 |
Why?
| | Proto-Oncogene Proteins | 9 | 2015 | 645 | 0.740 |
Why?
| | Corpus Luteum | 3 | 2016 | 20 | 0.730 |
Why?
| | Soybean Oil | 1 | 2021 | 14 | 0.730 |
Why?
| | Protein Kinase C-delta | 5 | 2009 | 44 | 0.730 |
Why?
| | Phospholipids | 2 | 2021 | 211 | 0.680 |
Why?
| | Gene Expression Regulation, Neoplastic | 9 | 2024 | 1341 | 0.670 |
Why?
| | Leiomyosarcoma | 1 | 2019 | 27 | 0.650 |
Why?
| | Cell Proliferation | 8 | 2024 | 2381 | 0.580 |
Why?
| | Insulin | 5 | 2022 | 2322 | 0.560 |
Why?
| | Apoptosis | 11 | 2024 | 2519 | 0.540 |
Why?
| | Fibroblast Growth Factors | 4 | 2021 | 172 | 0.540 |
Why?
| | Gene Expression Regulation | 11 | 2023 | 2549 | 0.520 |
Why?
| | Diet, High-Fat | 3 | 2024 | 240 | 0.520 |
Why?
| | High Fructose Corn Syrup | 1 | 2015 | 8 | 0.500 |
Why?
| | Granulosa Cells | 1 | 2015 | 32 | 0.490 |
Why?
| | Signal Transduction | 11 | 2021 | 4930 | 0.480 |
Why?
| | Weight Gain | 2 | 2016 | 508 | 0.480 |
Why?
| | Proto-Oncogene Proteins c-ets | 8 | 2007 | 53 | 0.470 |
Why?
| | Gene Products, tax | 2 | 2024 | 13 | 0.460 |
Why?
| | Human T-lymphotropic virus 1 | 2 | 2024 | 28 | 0.460 |
Why?
| | Fibroblast Growth Factor 2 | 3 | 2006 | 85 | 0.440 |
Why?
| | Dietary Fats | 1 | 2015 | 303 | 0.430 |
Why?
| | Adenocarcinoma | 3 | 2009 | 916 | 0.420 |
Why?
| | Transcription Factors | 8 | 2018 | 1649 | 0.400 |
Why?
| | Biomarkers, Tumor | 1 | 2019 | 1196 | 0.400 |
Why?
| | MAP Kinase Signaling System | 3 | 2006 | 311 | 0.400 |
Why?
| | DNA-Binding Proteins | 8 | 2018 | 1433 | 0.390 |
Why?
| | Gonadotropins | 3 | 2023 | 37 | 0.370 |
Why?
| | MicroRNAs | 2 | 2015 | 680 | 0.370 |
Why?
| | Aromatase Inhibitors | 3 | 2020 | 52 | 0.370 |
Why?
| | E2F Transcription Factors | 4 | 2023 | 59 | 0.360 |
Why?
| | Protein Kinase C | 2 | 2003 | 258 | 0.360 |
Why?
| | Cross-Over Studies | 3 | 2022 | 521 | 0.360 |
Why?
| | Fibroblast Growth Factor 4 | 3 | 2006 | 19 | 0.350 |
Why?
| | Cell Line, Tumor | 11 | 2024 | 3185 | 0.340 |
Why?
| | Homeodomain Proteins | 5 | 2012 | 495 | 0.340 |
Why?
| | Estradiol | 5 | 2023 | 498 | 0.330 |
Why?
| | Female | 36 | 2024 | 68842 | 0.330 |
Why?
| | Transcriptional Activation | 4 | 2024 | 363 | 0.310 |
Why?
| | JNK Mitogen-Activated Protein Kinases | 1 | 2009 | 161 | 0.310 |
Why?
| | RNA, Messenger | 2 | 2015 | 2732 | 0.300 |
Why?
| | Hydrocortisone | 2 | 2022 | 301 | 0.290 |
Why?
| | Tumor Suppressor Protein p53 | 2 | 2024 | 513 | 0.290 |
Why?
| | Menstrual Cycle | 2 | 2019 | 124 | 0.270 |
Why?
| | Ovarian Neoplasms | 1 | 2012 | 488 | 0.270 |
Why?
| | Humans | 45 | 2024 | 130305 | 0.260 |
Why?
| | Growth Hormone | 3 | 2022 | 96 | 0.260 |
Why?
| | Genes, Tumor Suppressor | 4 | 2023 | 87 | 0.250 |
Why?
| | Isoenzymes | 3 | 2003 | 305 | 0.250 |
Why?
| | Weight Loss | 2 | 2024 | 728 | 0.240 |
Why?
| | Cytokines | 4 | 2024 | 2016 | 0.240 |
Why?
| | Cell Cycle Proteins | 4 | 2023 | 585 | 0.240 |
Why?
| | DEAD-box RNA Helicases | 1 | 2024 | 63 | 0.230 |
Why?
| | Protein-Arginine N-Methyltransferases | 1 | 2024 | 28 | 0.220 |
Why?
| | Adipokines | 1 | 2024 | 46 | 0.220 |
Why?
| | Tumor Cells, Cultured | 5 | 2007 | 937 | 0.220 |
Why?
| | Live Birth | 1 | 2024 | 55 | 0.220 |
Why?
| | Phosphorylation | 5 | 2024 | 1709 | 0.220 |
Why?
| | Preconception Care | 1 | 2024 | 39 | 0.220 |
Why?
| | Cyclin-Dependent Kinases | 1 | 2024 | 130 | 0.210 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p21 | 2 | 2016 | 116 | 0.210 |
Why?
| | rac1 GTP-Binding Protein | 1 | 2003 | 55 | 0.210 |
Why?
| | Transcription Factor DP1 | 2 | 2023 | 21 | 0.210 |
Why?
| | Gonadotropin-Releasing Hormone | 4 | 2021 | 207 | 0.200 |
Why?
| | Fertility | 1 | 2024 | 163 | 0.200 |
Why?
| | Pituitary Hormones | 1 | 2022 | 16 | 0.200 |
Why?
| | Rats | 10 | 2006 | 5285 | 0.200 |
Why?
| | Mindfulness | 1 | 2024 | 116 | 0.200 |
Why?
| | Thyroid Hormones | 1 | 2022 | 54 | 0.190 |
Why?
| | Transcription Factor Pit-1 | 6 | 2003 | 24 | 0.190 |
Why?
| | Thyrotropin | 1 | 2022 | 109 | 0.190 |
Why?
| | Transcription, Genetic | 3 | 2009 | 1415 | 0.190 |
Why?
| | Hypothalamus | 2 | 2014 | 144 | 0.190 |
Why?
| | Animals | 19 | 2016 | 35076 | 0.190 |
Why?
| | Tandem Mass Spectrometry | 2 | 2015 | 453 | 0.190 |
Why?
| | Proto-Oncogene Proteins p21(ras) | 3 | 1997 | 265 | 0.180 |
Why?
| | Emulsions | 1 | 2021 | 44 | 0.180 |
Why?
| | Leptin | 1 | 2022 | 218 | 0.180 |
Why?
| | Thinness | 1 | 2021 | 90 | 0.180 |
Why?
| | Lipids | 2 | 2022 | 627 | 0.170 |
Why?
| | Heparin | 1 | 2022 | 252 | 0.170 |
Why?
| | Wnt Proteins | 1 | 2021 | 128 | 0.170 |
Why?
| | Fatty Acids, Nonesterified | 1 | 2021 | 159 | 0.170 |
Why?
| | Feasibility Studies | 1 | 2024 | 865 | 0.170 |
Why?
| | Adult | 17 | 2024 | 35711 | 0.170 |
Why?
| | Adiponectin | 1 | 2022 | 234 | 0.170 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p18 | 2 | 2016 | 11 | 0.170 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 2 | 2012 | 166 | 0.170 |
Why?
| | Proto-Oncogene Protein c-ets-1 | 6 | 2003 | 19 | 0.170 |
Why?
| | Creatinine | 1 | 2022 | 491 | 0.170 |
Why?
| | Bcl-2-Like Protein 11 | 2 | 2016 | 40 | 0.170 |
Why?
| | Enzyme Activation | 3 | 2009 | 817 | 0.170 |
Why?
| | Insulin-Like Growth Factor I | 1 | 2022 | 308 | 0.170 |
Why?
| | Chitinase-3-Like Protein 1 | 1 | 2019 | 20 | 0.160 |
Why?
| | Cell Cycle | 2 | 2015 | 587 | 0.160 |
Why?
| | Wnt Signaling Pathway | 1 | 2021 | 169 | 0.160 |
Why?
| | beta Catenin | 1 | 2021 | 223 | 0.160 |
Why?
| | Intramolecular Oxidoreductases | 1 | 2019 | 67 | 0.160 |
Why?
| | Biomarkers | 2 | 2024 | 3923 | 0.160 |
Why?
| | Eicosapentaenoic Acid | 1 | 2019 | 36 | 0.160 |
Why?
| | Cytoskeletal Proteins | 1 | 2019 | 142 | 0.150 |
Why?
| | Follicular Phase | 2 | 2015 | 40 | 0.150 |
Why?
| | Docosahexaenoic Acids | 1 | 2019 | 83 | 0.150 |
Why?
| | Gene Knockdown Techniques | 2 | 2009 | 320 | 0.150 |
Why?
| | Estrogens | 3 | 2019 | 355 | 0.150 |
Why?
| | Estrone | 2 | 2015 | 37 | 0.150 |
Why?
| | Pituitary Gland, Anterior | 1 | 1997 | 39 | 0.150 |
Why?
| | Microtubule-Associated Proteins | 1 | 2019 | 191 | 0.150 |
Why?
| | Immunoenzyme Techniques | 2 | 2009 | 215 | 0.150 |
Why?
| | Etoposide | 2 | 2009 | 149 | 0.140 |
Why?
| | Pregnancy | 4 | 2024 | 6301 | 0.140 |
Why?
| | Genes, p16 | 1 | 2016 | 20 | 0.140 |
Why?
| | Fibroblasts | 3 | 2018 | 953 | 0.130 |
Why?
| | Aromatase | 2 | 2014 | 31 | 0.130 |
Why?
| | Oncogene Proteins | 1 | 1996 | 54 | 0.130 |
Why?
| | Genes, ras | 2 | 1997 | 99 | 0.130 |
Why?
| | Stress, Psychological | 1 | 2024 | 1058 | 0.130 |
Why?
| | RNA-Binding Proteins | 1 | 2019 | 388 | 0.130 |
Why?
| | Young Adult | 10 | 2024 | 12404 | 0.120 |
Why?
| | Blotting, Western | 2 | 2009 | 1201 | 0.120 |
Why?
| | Ovulation | 1 | 2015 | 40 | 0.120 |
Why?
| | Dietary Supplements | 2 | 2019 | 534 | 0.120 |
Why?
| | Molecular Sequence Annotation | 1 | 2015 | 88 | 0.120 |
Why?
| | Cumulus Cells | 1 | 2015 | 6 | 0.120 |
Why?
| | Diagnosis, Differential | 1 | 2019 | 1442 | 0.120 |
Why?
| | Transcription Factors, TFII | 2 | 2024 | 40 | 0.120 |
Why?
| | Apoptosis Regulatory Proteins | 1 | 2015 | 183 | 0.120 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2016 | 362 | 0.120 |
Why?
| | Tumor Suppressor Protein p14ARF | 1 | 2014 | 7 | 0.120 |
Why?
| | Sensitivity and Specificity | 1 | 2019 | 1854 | 0.110 |
Why?
| | Blood Chemical Analysis | 1 | 2015 | 96 | 0.110 |
Why?
| | Fatty Acids, Omega-3 | 1 | 2015 | 139 | 0.110 |
Why?
| | Hormone Antagonists | 1 | 2014 | 30 | 0.110 |
Why?
| | Circadian Rhythm | 1 | 2017 | 404 | 0.110 |
Why?
| | Hypogonadism | 3 | 2024 | 82 | 0.110 |
Why?
| | Luteal Phase | 1 | 2014 | 44 | 0.110 |
Why?
| | Transfection | 3 | 2009 | 910 | 0.110 |
Why?
| | Repressor Proteins | 1 | 1997 | 402 | 0.110 |
Why?
| | Neoplasms, Experimental | 1 | 2014 | 172 | 0.110 |
Why?
| | RNA Interference | 2 | 2018 | 453 | 0.100 |
Why?
| | Exercise | 1 | 2024 | 1941 | 0.100 |
Why?
| | Culture Media, Serum-Free | 2 | 2003 | 50 | 0.100 |
Why?
| | Postmenopause | 1 | 2015 | 370 | 0.100 |
Why?
| | DNA Fingerprinting | 1 | 2012 | 25 | 0.100 |
Why?
| | RNA, Small Interfering | 2 | 2018 | 586 | 0.100 |
Why?
| | Base Sequence | 3 | 2012 | 2162 | 0.100 |
Why?
| | Breast Neoplasms | 3 | 2012 | 2139 | 0.100 |
Why?
| | Cell Line | 5 | 2018 | 2786 | 0.100 |
Why?
| | DNA, Complementary | 2 | 2012 | 271 | 0.100 |
Why?
| | Tumor Suppressor Proteins | 1 | 2014 | 315 | 0.100 |
Why?
| | Testosterone | 1 | 2015 | 383 | 0.090 |
Why?
| | Pulsatile Flow | 1 | 2011 | 60 | 0.090 |
Why?
| | Cell Survival | 2 | 2021 | 1098 | 0.090 |
Why?
| | Protein Isoforms | 2 | 2003 | 379 | 0.090 |
Why?
| | Pituitary Neoplasms | 2 | 2003 | 184 | 0.090 |
Why?
| | Neoplasms | 2 | 2023 | 2467 | 0.090 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 2 | 2012 | 962 | 0.090 |
Why?
| | Mutation | 1 | 2021 | 3723 | 0.080 |
Why?
| | Adiposity | 1 | 2015 | 507 | 0.080 |
Why?
| | Colony-Forming Units Assay | 1 | 2009 | 90 | 0.080 |
Why?
| | Infertility, Female | 2 | 2024 | 106 | 0.080 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2009 | 72 | 0.080 |
Why?
| | Glycogen Synthase Kinase 3 beta | 1 | 2009 | 69 | 0.080 |
Why?
| | Transforming Growth Factor beta | 1 | 2012 | 465 | 0.080 |
Why?
| | Luciferases | 1 | 2009 | 149 | 0.080 |
Why?
| | Inflammation | 2 | 2024 | 2721 | 0.080 |
Why?
| | Progesterone | 3 | 2016 | 244 | 0.080 |
Why?
| | Glycogen Synthase Kinase 3 | 1 | 2009 | 80 | 0.080 |
Why?
| | Models, Biological | 2 | 2016 | 1716 | 0.080 |
Why?
| | Cyclin D1 | 1 | 2009 | 64 | 0.080 |
Why?
| | Oligonucleotide Array Sequence Analysis | 2 | 2015 | 773 | 0.080 |
Why?
| | NIH 3T3 Cells | 1 | 2009 | 142 | 0.080 |
Why?
| | Mutant Proteins | 1 | 2009 | 98 | 0.080 |
Why?
| | Membrane Proteins | 1 | 2015 | 1121 | 0.080 |
Why?
| | Matrix Metalloproteinase 11 | 1 | 2008 | 4 | 0.080 |
Why?
| | High-Throughput Nucleotide Sequencing | 1 | 2012 | 489 | 0.080 |
Why?
| | PTEN Phosphohydrolase | 1 | 2009 | 158 | 0.080 |
Why?
| | RNA, Neoplasm | 1 | 2008 | 89 | 0.070 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 1 | 2009 | 278 | 0.070 |
Why?
| | Randomized Controlled Trials as Topic | 2 | 2024 | 1381 | 0.070 |
Why?
| | Myometrium | 1 | 2008 | 36 | 0.070 |
Why?
| | Neoplastic Stem Cells | 1 | 2012 | 387 | 0.070 |
Why?
| | DNA, Neoplasm | 1 | 2008 | 162 | 0.070 |
Why?
| | Rabbits | 1 | 2009 | 766 | 0.070 |
Why?
| | Mice, Nude | 1 | 2009 | 688 | 0.070 |
Why?
| | Cell Adhesion | 1 | 2009 | 454 | 0.070 |
Why?
| | Neoplasm Invasiveness | 1 | 2009 | 484 | 0.070 |
Why?
| | Proto-Oncogene Proteins c-akt | 1 | 2009 | 428 | 0.070 |
Why?
| | Active Transport, Cell Nucleus | 1 | 2007 | 113 | 0.070 |
Why?
| | DNA Primers | 1 | 2008 | 523 | 0.070 |
Why?
| | Subcellular Fractions | 1 | 2006 | 80 | 0.070 |
Why?
| | HeLa Cells | 2 | 2000 | 607 | 0.070 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p16 | 2 | 2016 | 69 | 0.070 |
Why?
| | Proto-Oncogene Proteins c-raf | 2 | 1997 | 45 | 0.070 |
Why?
| | DNA Damage | 1 | 2009 | 379 | 0.070 |
Why?
| | Mammary Glands, Human | 1 | 2007 | 64 | 0.070 |
Why?
| | Poly(ADP-ribose) Polymerases | 1 | 2006 | 89 | 0.070 |
Why?
| | Immunoprecipitation | 1 | 2006 | 160 | 0.070 |
Why?
| | Middle Aged | 3 | 2024 | 31322 | 0.070 |
Why?
| | Ultraviolet Rays | 1 | 2009 | 389 | 0.070 |
Why?
| | raf Kinases | 1 | 2006 | 11 | 0.070 |
Why?
| | Growth Hormone-Releasing Hormone | 1 | 2006 | 24 | 0.070 |
Why?
| | Autocrine Communication | 1 | 2006 | 45 | 0.060 |
Why?
| | Receptors, Growth Factor | 1 | 2006 | 55 | 0.060 |
Why?
| | Calcium-Calmodulin-Dependent Protein Kinases | 2 | 1997 | 181 | 0.060 |
Why?
| | Paracrine Communication | 1 | 2006 | 62 | 0.060 |
Why?
| | Protein Kinase Inhibitors | 2 | 2009 | 883 | 0.060 |
Why?
| | Caspases | 1 | 2006 | 249 | 0.060 |
Why?
| | Prostate | 1 | 2007 | 179 | 0.060 |
Why?
| | Antineoplastic Agents, Phytogenic | 1 | 2006 | 189 | 0.060 |
Why?
| | Prospective Studies | 4 | 2023 | 7131 | 0.060 |
Why?
| | Adolescent | 7 | 2021 | 20374 | 0.060 |
Why?
| | Reproduction | 1 | 2007 | 201 | 0.060 |
Why?
| | Hypothalamo-Hypophyseal System | 2 | 2017 | 176 | 0.060 |
Why?
| | ras Proteins | 1 | 2006 | 151 | 0.060 |
Why?
| | Mice | 4 | 2012 | 16832 | 0.060 |
Why?
| | Protein Binding | 2 | 2024 | 2120 | 0.060 |
Why?
| | Oncogene Protein p65(gag-jun) | 1 | 2004 | 2 | 0.060 |
Why?
| | Cell Movement | 1 | 2009 | 948 | 0.060 |
Why?
| | Pituitary Hormones, Anterior | 1 | 2024 | 7 | 0.060 |
Why?
| | Ideal Body Weight | 1 | 2024 | 4 | 0.060 |
Why?
| | Cyclin D2 | 1 | 2024 | 5 | 0.060 |
Why?
| | Cell Nucleus | 1 | 2007 | 580 | 0.060 |
Why?
| | Ovulation Induction | 2 | 2015 | 55 | 0.060 |
Why?
| | Mitogen-Activated Protein Kinases | 1 | 2006 | 316 | 0.060 |
Why?
| | Cyclin-Dependent Kinase 2 | 1 | 2024 | 38 | 0.060 |
Why?
| | Proto-Oncogene Proteins c-jun | 1 | 2004 | 52 | 0.060 |
Why?
| | Body Mass Index | 3 | 2021 | 2268 | 0.060 |
Why?
| | Interleukin-2 Receptor alpha Subunit | 1 | 2024 | 77 | 0.060 |
Why?
| | Jurkat Cells | 1 | 2024 | 136 | 0.060 |
Why?
| | Diet, Fat-Restricted | 1 | 2024 | 79 | 0.060 |
Why?
| | Pregnancy Rate | 1 | 2024 | 60 | 0.050 |
Why?
| | Thiocarbamates | 1 | 2003 | 6 | 0.050 |
Why?
| | Phospholipid Ethers | 1 | 2003 | 7 | 0.050 |
Why?
| | Bridged-Ring Compounds | 1 | 2003 | 13 | 0.050 |
Why?
| | Culturally Competent Care | 1 | 2024 | 56 | 0.050 |
Why?
| | Thiones | 1 | 2003 | 14 | 0.050 |
Why?
| | Norbornanes | 1 | 2003 | 14 | 0.050 |
Why?
| | Gene Expression | 2 | 2021 | 1487 | 0.050 |
Why?
| | E2F3 Transcription Factor | 1 | 2023 | 10 | 0.050 |
Why?
| | Follicle Stimulating Hormone, Human | 1 | 2023 | 11 | 0.050 |
Why?
| | Chromones | 1 | 2003 | 46 | 0.050 |
Why?
| | Abortion, Spontaneous | 1 | 2024 | 100 | 0.050 |
Why?
| | Immunohistochemistry | 1 | 2007 | 1711 | 0.050 |
Why?
| | Protein Domains | 1 | 2024 | 252 | 0.050 |
Why?
| | Thyroid Neoplasms | 1 | 2007 | 311 | 0.050 |
Why?
| | Cell Death | 1 | 2024 | 353 | 0.050 |
Why?
| | Androstadienes | 1 | 2003 | 107 | 0.050 |
Why?
| | Morpholines | 1 | 2003 | 126 | 0.050 |
Why?
| | Molecular Sequence Data | 4 | 2012 | 2854 | 0.050 |
Why?
| | Cluster Analysis | 2 | 2015 | 485 | 0.050 |
Why?
| | Models, Molecular | 1 | 2007 | 1486 | 0.050 |
Why?
| | Acetophenones | 1 | 2001 | 13 | 0.050 |
Why?
| | Benzopyrans | 1 | 2001 | 31 | 0.050 |
Why?
| | Focus Groups | 1 | 2024 | 447 | 0.050 |
Why?
| | Heterocyclic Compounds, 3-Ring | 1 | 2021 | 31 | 0.050 |
Why?
| | Naphthalenes | 1 | 2001 | 60 | 0.050 |
Why?
| | Transcription Factor CHOP | 1 | 2021 | 30 | 0.050 |
Why?
| | Carbazoles | 1 | 2001 | 85 | 0.050 |
Why?
| | Fat Emulsions, Intravenous | 1 | 2021 | 29 | 0.050 |
Why?
| | Immunoblotting | 1 | 2001 | 304 | 0.040 |
Why?
| | Inflammation Mediators | 1 | 2024 | 509 | 0.040 |
Why?
| | Indazoles | 1 | 2021 | 67 | 0.040 |
Why?
| | Mutagenesis, Site-Directed | 2 | 2004 | 359 | 0.040 |
Why?
| | Adenoviridae | 1 | 2001 | 194 | 0.040 |
Why?
| | Genetic Fitness | 1 | 2021 | 54 | 0.040 |
Why?
| | Self Efficacy | 1 | 2024 | 377 | 0.040 |
Why?
| | Endoplasmic Reticulum Stress | 1 | 2021 | 101 | 0.040 |
Why?
| | Glucose Clamp Technique | 1 | 2021 | 195 | 0.040 |
Why?
| | Heat-Shock Proteins | 1 | 2021 | 133 | 0.040 |
Why?
| | NF-kappa B | 1 | 2024 | 691 | 0.040 |
Why?
| | Aged | 1 | 2019 | 22282 | 0.040 |
Why?
| | Imidazoles | 1 | 2021 | 231 | 0.040 |
Why?
| | Epigenesis, Genetic | 1 | 2024 | 620 | 0.040 |
Why?
| | Disease Susceptibility | 1 | 2021 | 340 | 0.040 |
Why?
| | DNA | 2 | 1997 | 1412 | 0.040 |
Why?
| | Pancreatic Neoplasms | 1 | 2007 | 892 | 0.040 |
Why?
| | Histones | 1 | 2024 | 589 | 0.040 |
Why?
| | Progestins | 1 | 2019 | 78 | 0.040 |
Why?
| | Indoles | 1 | 2001 | 379 | 0.040 |
Why?
| | ADP-Ribosylation Factors | 1 | 2018 | 18 | 0.040 |
Why?
| | Feeding Behavior | 1 | 2024 | 621 | 0.040 |
Why?
| | Cell Differentiation | 1 | 2006 | 1896 | 0.040 |
Why?
| | Academic Medical Centers | 1 | 2021 | 476 | 0.040 |
Why?
| | Molecular Targeted Therapy | 1 | 2021 | 389 | 0.040 |
Why?
| | Recurrence | 1 | 2021 | 1020 | 0.040 |
Why?
| | Dimerization | 1 | 2018 | 189 | 0.040 |
Why?
| | Enzyme Inhibitors | 1 | 2001 | 832 | 0.040 |
Why?
| | Pyridines | 1 | 2021 | 474 | 0.040 |
Why?
| | Proto-Oncogene Protein c-ets-2 | 1 | 1997 | 3 | 0.040 |
Why?
| | Ectopic Gene Expression | 1 | 2016 | 4 | 0.030 |
Why?
| | Disease Management | 1 | 2021 | 597 | 0.030 |
Why?
| | ets-Domain Protein Elk-1 | 1 | 1996 | 13 | 0.030 |
Why?
| | Retinoblastoma Protein | 1 | 2016 | 54 | 0.030 |
Why?
| | Catalysis | 1 | 1997 | 309 | 0.030 |
Why?
| | Pituitary-Adrenal System | 1 | 2017 | 143 | 0.030 |
Why?
| | Transduction, Genetic | 1 | 1996 | 129 | 0.030 |
Why?
| | Hormones | 1 | 2016 | 140 | 0.030 |
Why?
| | Administration, Cutaneous | 1 | 2015 | 130 | 0.030 |
Why?
| | Oocyte Retrieval | 1 | 2015 | 12 | 0.030 |
Why?
| | Limit of Detection | 1 | 2015 | 57 | 0.030 |
Why?
| | Phosphoprotein Phosphatases | 1 | 2015 | 67 | 0.030 |
Why?
| | Neovascularization, Physiologic | 1 | 2016 | 181 | 0.030 |
Why?
| | Absorptiometry, Photon | 1 | 2015 | 250 | 0.030 |
Why?
| | Genes, Transgenic, Suicide | 1 | 2014 | 7 | 0.030 |
Why?
| | Trans-Activators | 1 | 1997 | 387 | 0.030 |
Why?
| | Binding Sites | 1 | 1997 | 1252 | 0.030 |
Why?
| | Cellular Microenvironment | 1 | 2015 | 79 | 0.030 |
Why?
| | Protein-Tyrosine Kinases | 1 | 1997 | 429 | 0.030 |
Why?
| | Recombinant Fusion Proteins | 1 | 1997 | 645 | 0.030 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2015 | 328 | 0.030 |
Why?
| | Chromosome Mapping | 1 | 1995 | 506 | 0.030 |
Why?
| | Ovary | 1 | 2015 | 214 | 0.030 |
Why?
| | Anions | 1 | 2013 | 31 | 0.030 |
Why?
| | Interleukin-1beta | 1 | 2015 | 378 | 0.030 |
Why?
| | Molecular Conformation | 1 | 2013 | 141 | 0.030 |
Why?
| | Chromatography, Liquid | 1 | 2015 | 375 | 0.030 |
Why?
| | Fatty Acids | 1 | 2015 | 416 | 0.030 |
Why?
| | Genetic Therapy | 1 | 2014 | 296 | 0.020 |
Why?
| | Sequence Homology, Nucleic Acid | 1 | 2012 | 150 | 0.020 |
Why?
| | Cardiovascular Diseases | 1 | 2024 | 2028 | 0.020 |
Why?
| | Heterografts | 1 | 2012 | 129 | 0.020 |
Why?
| | Gene Library | 1 | 2012 | 118 | 0.020 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2015 | 1210 | 0.020 |
Why?
| | Nitriles | 1 | 2011 | 162 | 0.020 |
Why?
| | Male | 4 | 2017 | 63748 | 0.020 |
Why?
| | Protein Kinases | 1 | 1992 | 307 | 0.020 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2015 | 825 | 0.020 |
Why?
| | Triazoles | 1 | 2011 | 155 | 0.020 |
Why?
| | Treatment Outcome | 1 | 2024 | 10341 | 0.020 |
Why?
| | Sequence Analysis, DNA | 1 | 2012 | 780 | 0.020 |
Why?
| | Drug Administration Schedule | 1 | 2011 | 766 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 2017 | 5083 | 0.020 |
Why?
| | Receptors, Pituitary Hormone-Regulating Hormone | 1 | 2006 | 8 | 0.020 |
Why?
| | Receptors, Neuropeptide | 1 | 2006 | 12 | 0.020 |
Why?
| | Transcriptome | 1 | 2012 | 890 | 0.020 |
Why?
| | Prognosis | 1 | 2012 | 3830 | 0.010 |
Why?
| | Liver | 1 | 1992 | 1846 | 0.010 |
Why?
| | Suppression, Genetic | 1 | 2003 | 24 | 0.010 |
Why?
| | Genes, Dominant | 1 | 2003 | 92 | 0.010 |
Why?
| | Genetic Vectors | 1 | 2004 | 314 | 0.010 |
Why?
| | Disease Models, Animal | 1 | 2012 | 4044 | 0.010 |
Why?
| | Amino Acid Sequence | 2 | 1997 | 2060 | 0.010 |
Why?
| | Phosphothreonine | 1 | 1997 | 6 | 0.010 |
Why?
| | Sequence Alignment | 1 | 1997 | 334 | 0.010 |
Why?
| | Sequence Homology, Amino Acid | 1 | 1997 | 373 | 0.010 |
Why?
| | Structure-Activity Relationship | 1 | 1997 | 541 | 0.010 |
Why?
| | Drosophila Proteins | 1 | 1997 | 190 | 0.010 |
Why?
| | Biological Evolution | 1 | 1997 | 428 | 0.010 |
Why?
| | Nerve Tissue Proteins | 1 | 1997 | 572 | 0.010 |
Why?
| | Chromatography, Ion Exchange | 1 | 1992 | 52 | 0.010 |
Why?
| | Chromatography, Gel | 1 | 1992 | 127 | 0.010 |
Why?
| | Rats, Inbred Strains | 1 | 1992 | 366 | 0.010 |
Why?
| | Molecular Weight | 1 | 1992 | 333 | 0.010 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 1 | 1992 | 327 | 0.010 |
Why?
| | Cytosol | 1 | 1992 | 211 | 0.010 |
Why?
| | Peptides | 1 | 1997 | 917 | 0.010 |
Why?
| | Substrate Specificity | 1 | 1992 | 373 | 0.010 |
Why?
| | Oligopeptides | 1 | 1992 | 258 | 0.010 |
Why?
| | Cells, Cultured | 1 | 1997 | 4106 | 0.000 |
Why?
| | Kinetics | 1 | 1992 | 1634 | 0.000 |
Why?
|
|
Bradford's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|